Comparison of demographic and clinical data between patients with/without venous thromboembolic events (VTEs)
| Patients with VTE (n=15) | Patients without VTE (n=158) | Significance (p value) | |
| Age in years (mean ± SD) | 60.2 ± 10.5 | 69.5 ± 12.2 | 0.004* |
| Sex (female (%)) | 4 (26.7) | 64 (40.5) | 0.294† |
| Pre-mRS (mean ± SD) | 0.3 ± 0.7 | 0.6 ± 1.1 | 0.600* |
| First NIHSS (mean ± SD) | 16.6 ± 7.6 | 18.3 ± 8.4 | 0.187* |
| Systemic thrombolysis (n (%)) | 7 (46.7) | 66 (41.8) | 0.714* |
| EVT (n (%)) | 11 (73.3) | 101 (63.9) | 0.466† |
| Decompressive hemicraniectomy (n (%)) | 11 (73.3) | 42 (26.6) | <0.001†* |
| First APACHE II (mean ± SD) | 12.1 ± 4.0 | 12.7 ± 4.7 | 0.623* |
| First SAPS 2 (mean ± SD) | 28.9 ± 6.0 | 33.0 ± 11.8 | 0.193* |
| Arterial hypertension (n (%)) | 11 (73.3) | 129 (81.6) | 0.434† |
| Current smoking (n (%)) | 5 (33.3) | 45 (28.5) | 0.691† |
| Atrial fibrillation (n (%)) | 2 (13.3) | 41 (25.9) | 0.280† |
| Anticoagulation at admission (n (%)) | 1 (6.7) | 35 (22.2) | 0.158† |
| Carcinoma | |||
| Active (n (%)) | 4 (26.7) | 5 (3.2) | |
| Status post (n (%)) | 2 (13.3) | 18 (11.4) | |
| None (n (%)) | 9 (60.0) | 135 (85.4) | |
| DVT in medical history (n (%)) | 2 (13.3) | 7 (4.4) | 0.138† |
| PE in medical history (n (%)) | 1 (6.7) | 4 (2.5) | 0.361† |
| Duration of central venous catheters in days (mean ± SD) | 21.2 ± 9.4 n = 14 (93.3 %) | 13.2 ± 8.4 n = 121 (76.6%) | 0.003* |
| Interval from admission to first (passive) mobilisation to the edge of the patient’s bed (in days, mean ± SD) | 11.1 ± 11.3 | 3.8 ± 7.3 | 0.496* |
*Mann-Whitney U test.
†χ2 test.
APACHE, Acute Physiology And Chronic Health Evaluation; DVT, deep vein thrombosis; EVT, endovascular treatment; mRS, modified Rankin Scale; NIHSS, National Institute of Health Stroke Scale; PE, pulmonary embolism; SAPS 2, Simplified Acute Physiology Score 2.